REFERENCES
- Storkel S, Eble JN, Adlakha K, . Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987–989.
- Tickoo SK, Reuter VE, Amin MB, . Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol. 1999;23:1094–1101.
- Katzman PJ, Schwartz JI. Chromophobe renal cell carcinoma in a child: case report and review of the literature. Pediatr Dev Pathol. 2007;10:125–128.
- Mai KT, Dhamanaskar P, Belanger E, . Hybrid chromophobe renal cell neoplasm. Pathol Res Pract. 2005;201:385–389.
- Amin MB, Tamboli P, Javidan J, . Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281–291.
- Renshaw AA, Henske EP, Loughlin KR, . Aggressive variants of chromophobe renal cell carcinoma. Cancer. 1996;78:1756–1761.
- Delongchamps NB, Galmiche L, Eiss D, . Hybrid tumour ‘oncocytoma-chromophobe renal cell carcinoma’ of the kidney: a report of seven sporadic cases. BJU Int. 2009;103:1381–1384.
- Waldert M, Klatte T, Haitel A, . Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol. In press.
- Zini L, Leroy X, Lemaitre L, . Tumour necrosis in chromophobe renal cell carcinoma: clinical data to distinguish aggressive variants. Eur J Surg Oncol. 2008;34:687–691.
- Varan A, Akyuz C, Sari N, . Renal cell carcinoma in children: experience of a single center. Nephron Clin Pract. 2007;105:c58–61.
- Krejci KG, Blute ML, Cheville JC, . Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology. 2003;62:641–646.
- Cook A, Lorenzo AJ, Salle JL, . Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol. 2006;175:1456–1460; discussion 1460.
- Duque JL, Loughlin KR, O’Leary MP, . Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology. 1998;52:584–590.